Lorraine K. Fay

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor

Douglas S. Johnson, Cory M. Stiff, Scott E. Lazerwith et al. · ACS Medicinal Chemistry Letters · 2010 · 196 citations · Full text

Pharmaceutical Science, Molecular Pain, Pharmacotherapy +19

Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)

Douglas S. Johnson, Kay Ahn, Suzanne R. Kesten et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 63 citations

Bioorganic Chemistry, Biochemistry, Natural Sciences +8

Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder

Douglas S. Johnson, Chung Sik Choi, Lorraine K. Fay et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 27 citations · Full text

Psychoactive Drug, Psychiatry, Medicine +9

Design, Synthesis, and Biological Activity of Novel Polycyclic Aza-Amide FKBP12 Ligands

Raymond A. Hudack, Nancy S. Barta, Chuangxing Guo et al. · Journal of Medicinal Chemistry · 2006 · 22 citations · Full text

Combinatorial Chemistry, Drug Target, Unique Series +17

Siblings of children with mental retardation: Family characteristics and adjustment

Denis J. Lynch, Lorraine K. Fay, Jeanne B. Funk et al. · Journal of Child and Family Studies · 1993 · 14 citations

Child Psychology, Developmental Disability, Child Mental Health +14